AGENUS INC - 12 Oct 2023 Form 4 Insider Report for MiNK Therapeutics, Inc. (INKT)

Role
10%+ Owner
Signature
/s/Christine Klaskin, Vice President, Finance
Issuer symbol
INKT
Transactions as of
12 Oct 2023
Net transactions value
+$25,270
Form type
4
Filing time
16 Oct 2023, 17:49:39 UTC
Previous filing
06 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INKT Common Stock Purchase $3,488 +3,173 +0.01% $1.10 21,753,061 12 Oct 2023 Direct F1, F2
transaction INKT Common Stock Purchase $21,310 +19,373 +0.09% $1.10 21,772,434 13 Oct 2023 Direct F2, F3
transaction INKT Common Stock Purchase $472 +429 +0% $1.10 21,772,863 16 Oct 2023 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Open market purchases reported on this line occurred at a weighted average price of $1.0994 (range of $1.08 to $1.10).
F2 Agenus Inc. undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price.
F3 Open market purchases reported on this line occurred at a price of $1.10.
F4 Open market purchases reported on this line occurred at a weighted average price of $1.0992 (range of $1.09 to $1.10).